查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1540962

2024-2032 年按組件、應用、技術、最終用戶和地區分類的基因組學市場報告

Genomics Market Report by Component, Application, Technology, End-User, and Region 2024-2032
出版日期: | 出版商: IMARC | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

2023年全球基因體學IMARC Group規模達339億美元。全球基因組學研究的政府和私人資金不斷增加、基因組學在藥物發現和開發中的應用不斷增加，以及人們對基因組學見解在改善健康結果方面的潛在好處的認知不斷提高，推動了該市場的穩定成長。

基因組學市場分析：

主要市場促進因素：基因定序技術的進步和對個人化醫療日益成長的興趣推動了基因組學市場的成長。研發投資至關重要，推動基因組學市場價值上升。

主要市場趨勢：基因組學中人工智慧（AI）和機器學習（ML）的整合參考了關鍵基因組學市場趨勢，增強了基因組學市場研究能力。這種趨勢有助於完善預測模型，從而實現精確的基因組學市場預測。 CRISPR基因編輯技術的採用凸顯了治療應用的重大轉變，直接影響基因組學市場需求。

地理趨勢：由於其先進的醫療基礎設施以及對研究和創新的高度重視，北美在基因組學市場收入方面佔據主導地位。在政府舉措的增加和對基因組學研究的日益關注的推動下，亞太地區顯示出最快的基因組學市場成長率。這種擴張提供了多樣化的基因組學市場概況，標誌著不同地區不同的成長前景。

競爭格局：基因組學領域的著名市場參與者包括 Illumina, Inc.、Thermo Fisher Scientific、QIAGEN、Agilent Technologies、Oxford Nanopore Technologies 和 CRISPR Therapeutics 等。這些實體對於確定基因組學市場前景至關重要，其競爭策略和創新對市場收入做出了重大貢獻。

挑戰與機會：與遺傳資料相關的倫理問題以及與基因組定序相關的高成本給基因組學市場帶來了挑戰。然而，這些挑戰也帶來了創新機會，以滿足不斷成長的基因組學市場需求。開發具有成本效益的測序方法並建立道德準則可以進一步提升基因組學市場價值並促進基因組學市場成長。

基因組學市場趨勢：

定序技術的技術創新

根據基因組學市場分析，創新進步的快節奏，特別是次世代定序 (NGS) 和 CRISPR-Cas9 基因組改變創新，是基因組學展示的重要驅動力。這些進展從根本上降低了成本、提高了速度並提高了精度，徹底改變了遺傳研究，從而使基因組測序在更廣泛的行業中更加可用和適用。 NGS 創新的進步使分析人員能夠比已經使用的桑格測序更快、更便宜地排列 DNA 和 RNA，從而加快了基因組學的步伐。這種機械進步正在增加個人化醫療、農業基因組學和微生物基因組學等，催化了該領域內的先進企業和陰謀。

個人化醫療需求不斷成長

市場的另一個重要驅動力是全球對個人化醫療的需求不斷成長，即根據每個患者的獨特特徵量身定做醫療護理。客製化醫療在很大程度上依賴基因資料，以指導針對個別基因組成客製化特定療法的創建，從而擺脫傳統醫學的通用方法，轉向更準確、更有效的治療。這也有助於提高消費者的意識，幫助他們找到「基因組市場是什麼？」的答案。問題。同時，對疾病遺傳原因的認知和了解的不斷擴大、遺傳病症發生頻率的增加以及各種疾病的常規療法的局限性也推動了日益成長的需求。在個人化醫療中使用基因組學旨在提高患者治療效果，並透過優先考慮預防和準確治療來提供具有成本效益的醫療保健方法，從而推動對基因組學的更多投資和研究。

臨床應用和診斷的擴展

由於基因組學技術更多地用於臨床應用和診斷，例如識別遺傳性疾病、癌症篩檢和監測傳染病，該市場也在不斷成長。對疾病遺傳基礎的進一步了解使得基因組學能夠納入臨床護理，從而創造出新的診斷工具和基因測試，可以預測個體特定疾病的風險，指導治療選擇並追蹤疾病進展。出現了一個問題，基因體學的需求是什麼，特別是在臨床應用和診斷領域？基因組學技術的進步預計將繼續推動該領域的需求，擴大其在液體活體組織切片和 NIPT 等診斷領域的潛力，凸顯基因組學在醫療保健和診斷革命中發揮的關鍵作用。

基因組學市場細分：

IMARC Group提供了每個細分市場的主要趨勢分析，以及 2024-2032 年全球、區域和國家層面的預測。我們的報告根據組件、應用、技術和最終用戶對市場進行了分類。

按組件分類：

產品

儀器和軟體

耗材和試劑

服務

核心基因組學服務

基於 NGS 的服務

生物標記翻譯服務

計算服務

其他

耗材和試劑佔據大部分市場佔有率

該報告根據組成部分提供了詳細的市場細分和分析。這包括產品（儀器和軟體、消耗品和試劑）、服務（核心基因組學服務、基於 NGS 的服務、生物標記翻譯服務、計算服務等）。根據該報告，消耗品和試劑佔據了最大的部分。

消耗品和試劑領域因其在 DNA 定序、基因編輯和樣品製備等各種基因組程序中發揮的重要作用而佔據市場主導地位。隨著基因組學在醫療保健、農業和生物技術等領域的使用不斷增加，對特定耗材和試劑的需求不斷增加，導致製造商增強和擴展其產品範圍。這正在促進耗材產業的發展，強調其在驅動和應用基因組學技術方面的關鍵作用，為市場的整體成長做出重大貢獻。此外，對這些產品的強勁需求進一步鞏固了該行業的主導地位，這些產品對於確保研究和臨床診斷中基因組分析的準確性和可靠性至關重要。

按應用分類：

功能基因體學

表觀基因組學

生物標記發現

通路分析

其他

功能基因組學佔據行業最大佔有率

報告還提供了基於應用程式的詳細市場細分和分析。這包括功能基因組學、表觀基因組學、生物標記發現、路徑分析等。報告稱，功能基因組學佔據最大的市場佔有率。

功能基因組學專注於基因功能和相互作用，已成為市場的主導領域，展示了其在理解複雜的生物過程和疾病機制方面的至關重要性。在功能基因體學中利用RNA定序和CRISPR-Cas9等高通量技術可以深入研究基因表現和調控，從而推動生物醫學研究和醫療保健的進步。此外，人們越來越重視探索基因組的功能特徵，加上科技的快速進步，使功能基因體學成為推動整個市場成長和創新的主要力量。

按技術分類：

定序

微陣列

聚合酶鍊式反應

核酸萃取與純化

其他

測序代表了領先的細分市場

該報告基於該技術對市場進行了詳細的細分和分析。這包括定序、微陣列、聚合酶鍊式反應、核酸萃取和純化等。根據該報告，定序代表了最大的部分。

定序技術是市場的主要組成部分，因為它在破解 DNA 和 RNA 中的遺傳訊息方面發揮著至關重要的作用，使其成為最大的技術領域。定序提供的關鍵見解透過揭示遺傳變異和突變，推動了個人化醫療、基因研究和診斷應用的突出地位。此外，NGS 技術的興起正在改變這一領域，與傳統技術相比，它提供了無與倫比的速度、準確性和成本效益。 NGS 能夠對基因組、外顯子組和轉錄組進行詳細分析，從而在理解複雜疾病、演化生物學和微生物基因組學方面取得進展。

按最終用戶分類：

研究中心

醫院和診所

製藥和生物技術公司

其他

製藥和生物技術公司在市場上表現出明顯的主導地位

報告還提供了基於最終用戶的詳細市場細分和分析。這包括研究中心、醫院和診所、製藥和生物技術公司等。報告稱，製藥和生物技術公司佔據了最大的市場佔有率。

製藥和生物技術公司在市場上發揮著重要作用，強調它們在推動藥物開發和個人化醫療向前發展方面的重要性。這些領域應用基因組資料來識別藥物的新標靶，了解疾病的遺傳起源，並利用個人的遺傳資料開發客製化的治療方法。例如，全球 DNA 定序和陣列技術領域的頂級公司 Illumina Inc. 與范德比爾特大學醫學中心 (VUMC) 子公司、著名的臨床和基因組資料公司 Nashville Biosciences, LLC 合作，揭示了基因組發現聯盟（AGD）的五名原始成員。擴展協議旨在透過進行徹底的基因組學研究和建立高品質的臨床基因組資料庫來加快治療開發進程。艾伯維 (AbbVie)、安進 (Amgen)、阿斯特捷利康 (AstraZeneca)、拜耳 (Bayer) 和默克 (Merck) 將集中資源資助 250,000 個樣本的測序，並利用這些資料開發藥物和改進療法。

按地區分類：

北美洲

美國

加拿大

亞太地區

中國

日本

印度

韓國

澳洲

印尼

其他

歐洲

德國

法國

英國

義大利

西班牙

俄羅斯

其他

拉丁美洲

巴西

墨西哥

其他

中東和非洲

北美市場領先，佔據最大的基因組市場佔有率

該報告還對所有主要區域市場進行了全面分析，其中包括北美（美國和加拿大）；歐洲（德國、法國、英國、義大利、西班牙、俄羅斯等）；亞太地區（中國、日本、印度、韓國、澳洲、印尼等）；拉丁美洲（巴西、墨西哥等）；以及中東和非洲。報告稱，北美是基因體學最大的區域市場。

北美由於其先進的醫療保健系統、對研發的大量投資以及頂級製藥和生物技術公司的存在而擁有最大的市場佔有率。此外，該地區在基因組學和生物資訊學方面的先進技術以及這些因素正在為基因組學領域的發展和進步創造有利的環境。學術和研究機構與產業之間的密切合作支撐了北美在全球市場中的強勢地位，從而帶來了創新並設定了影響全球基因組學實踐和政策的趨勢。

競爭格局：

市場研究報告也對市場競爭格局進行了全面分析。也提供了所有主要公司的詳細資料。基因組學行業的一些主要市場參與者包括

23andMe 公司

安捷倫科技公司

拜耳公司

華大基因集團

Bio-Rad 實驗室有限公司

丹納赫公司

照明公司

牛津奈米孔技術公司

珀金埃爾默公司

無數遺傳學公司

F.霍夫曼-拉羅氏有限公司

賽默飛世爾科技公司

（請注意，這只是關鍵參與者的部分列表，報告中提供了完整列表。）

該行業的主要參與者參與各種策略活動，以維護和加強其市場地位。這些企業正在研發方面進行大量投資，以推出新的基因組技術、服務和解決方案，以滿足客戶不斷變化的需求。合作、建立合作夥伴關係和進行收購是重要的策略，使他們能夠增強技術能力、進入新市場、獲得新的基因組應用和智慧財產權。此外，這些頂尖公司也致力於改進其生物資訊系統，以管理和分析基因組定序產生的大量資料。這使得完整的解決方案能夠幫助將基因組發現轉化為臨床和農業領域的進展。

基因組學市場新聞：

2023 年 10 月 30 日：23andMe, Inc 宣布與 GSK plc 達成一項新的非獨家資料協議，該協議擴大了雙方的合作夥伴關係，並賦予GSK 使用23andMe 數據庫（最大的遺傳和表現型資訊集合）進行藥物標靶發現和其他研究的能力來自同意的參與者，可以再次聯繫。根據合作協議的修訂版，23andMe 將獲得 2000 萬美元的首期付款，以獲得為期一年的非獨家資料許可。

2023 年 3 月 14 日：安捷倫科技公司宣布與安捷倫合作提供完整的癌症分析解決方案。此次合作將把 SOPHiA DDM 平台與安捷倫新的僅供研究使用的 SureSelect 癌症綜合基因組分析 (CGP) 檢測試劑盒整合。這將使臨床研究人員能夠精確檢測多種生物標記物，減少忽視癌症樣本中關鍵資訊的機會。

本報告回答的關鍵問題

  • 2023年全球基因組市場規模有多大
  • 2024-2032年全球基因組市場的預期成長率是多少
  • 推動全球基因組學市場的關鍵因素是什麼
  • COVID-19 對全球基因組學市場有何影響
  • 全球基因組學市場按組成部分分類是怎樣的
  • 基於應用的全球基因組學市場的細分是什麼
  • 基於該技術的全球基因組學市場的細分是什麼
  • 基於最終用戶的全球基因組學市場的細分是什麼
  • 全球基因組市場的關鍵區域有哪些
  • 10. 全球基因體學市場的主要參與者/公司有哪些？

本報告回答的關鍵問題

  • 2023 年全球基因體學市場規模有多大？ 2024-2032年全球基因體學市場的預期成長率是多少？
  • 推動全球基因組學市場的關鍵因素是什麼？
  • COVID-19 對全球基因體學市場有何影響？
  • 全球基因組學市場按組成部分分類是怎樣的？
  • 根據應用，全球基因組學市場的細分如何？
  • 基於該技術的全球基因體學市場的分化是什麼？
  • 基於最終用戶的全球基因組學市場的細分是什麼？
  • 全球基因組學市場的關鍵區域有哪些？
  • 誰是全球基因組學市場的主要參與者/公司？

目錄

第1章：前言

第 2 章：範圍與方法

  • 研究目的
  • 利害關係人
  • 數據來源
    • 主要來源
    • 二手資料
  • 市場預測
    • 自下而上的方法
    • 自上而下的方法
  • 預測方法

第 3 章：執行摘要

第 4 章：簡介

  • 概述
  • 主要行業趨勢

第 5 章：全球基因組市場

  • 市場概況
  • 市場表現
  • COVID-19 的影響
  • 市場預測

第 6 章：市場區隔：按組成部分

  • 產品
    • 市場趨勢
    • 主要類型
      • 儀器和軟體
      • 耗材和試劑
    • 市場預測
  • 服務
    • 市場趨勢
    • 主要類型
      • 核心基因組學服務
      • 基於 NGS 的服務
      • 生物標記翻譯服務
      • 計算服務
      • 其他
    • 市場預測

第 7 章：市場區隔：按應用

  • 功能基因體學
    • 市場趨勢
    • 市場預測
  • 表觀基因組學
    • 市場趨勢
    • 市場預測
  • 生物標記發現
    • 市場趨勢
    • 市場預測
  • 通路分析
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 8 章：市場區隔：依技術

  • 定序
    • 市場趨勢
    • 市場預測
  • 微陣列
    • 市場趨勢
    • 市場預測
  • 聚合酶鍊式反應
    • 市場趨勢
    • 市場預測
  • 核酸萃取與純化
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 9 章：市場區隔：按最終用戶

  • 研究中心
    • 市場趨勢
    • 市場預測
  • 醫院和診所
    • 市場趨勢
    • 市場預測
  • 製藥和生物技術公司
    • 市場趨勢
    • 市場預測
  • 其他
    • 市場趨勢
    • 市場預測

第 10 章：市場區隔：按地區

  • 北美洲
    • 美國
    • 加拿大
  • 亞太地區
    • 中國
    • 日本
    • 印度
    • 韓國
    • 澳洲
    • 印尼
    • 其他
  • 歐洲
    • 德國
    • 法國
    • 英國
    • 義大利
    • 西班牙
    • 俄羅斯
    • 其他
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 其他
  • 中東和非洲
    • 市場趨勢
    • 市場細分：按國家/地區
    • 市場預測

第 11 章：SWOT 分析

  • 概述
  • 優勢
  • 弱點
  • 機會
  • 威脅

第 12 章：價值鏈分析

第 13 章：波特五力分析

  • 概述
  • 買家的議價能力
  • 供應商的議價能力
  • 競爭程度
  • 新進入者的威脅
  • 替代品的威脅

第 14 章：價格指標

第15章：競爭格局

  • 市場結構
  • 關鍵參與者
  • 關鍵參與者簡介
    • 23andMe, Inc.
    • Agilent Technologies, Inc.
    • Bayer Aktiengesellschaft
    • BGI Genomics Co. Ltd.
    • Bio-RAD Laboratories Inc.
    • Danaher Corporation
    • Illumina Inc.
    • Oxford Nanopore Technologies
    • PerkinElmer Inc.
    • Myriad Genetics Inc.
    • Roche Holding AG
    • Thermo Fisher Scientific Inc.
Product Code: SR112024A2246

The global genomics market size reached US$ 33.9 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 107.5 Billion by 2032, exhibiting a growth rate (CAGR) of 13.3% during 2024-2032. The market is experiencing steady growth driven by the escalating government and private funding for genomics research across the globe, the rising application of genomics in drug discovery and development, and rising awareness of the potential benefits of genomic insights in improving health outcomes.

Genomics Market Analysis:

Major Market Drivers: The genomics market growth is driven by advancements in genetic sequencing technologies and an increasing interest in personalized medicine. Investments in R&D are pivotal, pushing the genomics market value upwards.

Key Market Trends: Artificial intelligence (AI) and machine learning (ML) integration in genomics refer to the key genomics market trends, enhancing genomics market research capabilities. This trend aids in refining predictive modeling, leading to precise genomics market forecasts. The adoption of CRISPR gene editing technology highlights a significant shift in therapeutic applications, directly influencing genomics market demand.

Geographical Trends: North America dominates in terms of genomics market revenue, due to its advanced healthcare infrastructure and a strong focus on research and innovation. The Asia-Pacific region shows the fastest genomics market growth rate, propelled by increasing government initiatives and a burgeoning focus on genomics research. This expansion offers a diverse genomics market overview, signaling varied growth prospects across different regions.

Competitive Landscape: Notable market players in the genomics sector include Illumina, Inc., Thermo Fisher Scientific, QIAGEN, Agilent Technologies, Oxford Nanopore Technologies, and CRISPR Therapeutics, among others. These entities are crucial in determining the genomics market outlook, with their competitive strategies and innovations significantly contributing to the market revenue.

Challenges and Opportunities: Ethical concerns related to genetic data and the high costs associated with genomic sequencing pose challenges in the genomics market. Yet, these challenges also unveil opportunities for innovation to meet the increasing genomics market demand. Developing cost-effective sequencing methods and establishing ethical guidelines could further bolster the genomics market value and facilitate genomics market growth.

Genomics Market Trends:

Technological innovations in sequencing technologies

According to the genomics market analysis, the fast pace of innovative advancements, especially in next-generation sequencing (NGS) and CRISPR-Cas9 genome altering innovations, serves as an essential driver for the genomics showcase. These headways have revolutionized hereditary investigation by essentially diminishing costs, expanding speed, and moving forward precision, subsequently making genomic sequencing more available and appropriate over a wide extend of businesses. Advancements in NGS innovations have empowered analysts to arrange DNA and RNA much more rapidly and cheaply than the already utilized Sanger sequencing, and as a result, have quickened the pace of genomics. This mechanical advance is increasing personalized medication, agrarian genomics, and microbial genomics, among others, catalyzing advanced ventures and intrigue within the field.

Growing demand for personalized medicine

Another important driver of the market is the rising across the globe need for personalized medicine, which customizes medical care according to each patient's unique characteristics. Customized medical treatment depends greatly on genetic data to inform the creation of specific therapies tailored to an individual's genetic composition, moving away from the generalized approach of traditional medicine to more accurate and efficient treatments. This also facilitates enhanced awareness among consumers that helps them find an answer for the "what is the genomics market?" question. Along with this, the increasing need is fueled by the expanding recognition and knowledge of the genetic causes of diseases, the increasing frequency of genetic conditions, and the limitations of conventional therapies for various illnesses. Using genomics in personalized medicine aims to enhance patient results and provides a cost-effective healthcare approach by prioritizing prevention and accurate treatment, which drives more investments and research in genomics.

Expansion in clinical applications and diagnostics

The market is also growing due to genomics technologies being utilized more for clinical applications and diagnostics, such as identifying genetic disorders, cancer screening, and monitoring infectious diseases. Improved understanding of the genetic basis of diseases has allowed for the incorporation of genomics into clinical care, resulting in the creation of novel diagnostic tools and genetic tests that can anticipate an individual's risk for specific conditions, guide treatment choices, and track disease advancement. A question arises, what is the demand for genomics, particularly in the field of clinical applications and diagnostics? Advancements in genomics technologies are anticipated to keep driving demand in this field, expanding their potential in diagnostics such as liquid biopsies and NIPT, highlighting the critical role genomics plays in revolutionizing healthcare and diagnostics.

Genomics Market Segmentation:

IMARC Group provides an analysis of the key trends in each segment of the market, along with forecasts at the global, regional, and country levels for 2024-2032. Our report has categorized the market based on component, application, technology, and end-user.

Breakup by Component:

Products

Instruments and Software

Consumables and Reagents

Services

Core Genomics Services

NGS-Based Services

Biomarker Translation Services

Computational Services

Others

Consumables and reagents account for the majority of the market share

The report has provided a detailed breakup and analysis of the market based on the component. This includes products (instruments and software, consumables and reagents), services (core genomics services, NGS-based services, biomarker translation services, computational services, and others). According to the report, consumables and reagents represented the largest segment.

The consumables and reagents sector dominates the market due to their essential role in a variety of genomic procedures including DNA sequencing, gene editing, and sample preparation. With the increased use of genomics in sectors such as healthcare, agriculture, and biotechnology, there is a rising need for specific consumables and reagents, leading manufacturers to enhance and extend their product range. This is promoting the development of the consumables industry, emphasizing its crucial role in driving and applying genomics technologies, making a substantial contribution to the market's overall growth. Moreover, the strong demand for these products, which are essential for ensuring the accuracy and reliability of genomic analyses in research and clinical diagnostics, further solidifies the dominance of this industry sector.

Breakup by Application:

Functional Genomics

Epigenomics

Biomarkers Discovery

Pathway Analysis

Others

Functional genomics holds the largest share of the industry

A detailed breakup and analysis of the market based on the application have also been provided in the report. This includes functional genomics, epigenomics, biomarkers discovery, pathway analysis, and others. According to the report, functional genomics accounted for the largest market share.

Functional genomics, which focuses on gene functions and interactions, has become the dominant area in the market, showcasing its crucial importance in comprehending intricate biological processes and disease mechanisms. Utilizing high-throughput technologies including RNA sequencing and CRISPR-Cas9 in functional genomics enables in-depth study of gene expression and regulation, leading to progress in biomedical research and healthcare. Moreover, the growing emphasis on exploring the functional characteristics of the genome, along with the quick advancements in technology, positions functional genomics as a major force driving growth and innovation in the overall market.

Breakup by Technology:

Sequencing

Microarray

Polymerase Chain Reaction

Nucleic Acid Extraction and Purification

Others

Sequencing represents the leading market segment

The report has provided a detailed breakup and analysis of the market based on the technology. This includes sequencing, microarray, polymerase chain reaction, nucleic acid extraction and purification, and others. According to the report, sequencing represented the largest segment.

Sequencing technology is the main component of the market due to its crucial role in deciphering the genetic information found in DNA and RNA, making it the largest technological segment. The critical insights provided by sequencing drive this prominence in personalized medicine, genetic research, and diagnostic applications by uncovering genetic variations and mutations. Furthermore, the rise of NGS technologies is changing this field by offering unparalleled speed, accuracy, and cost-efficiency compared to traditional techniques. NGS enables a detailed analysis of genomes, exomes, and transcriptomes, allowing for progress in comprehending complex diseases, evolutionary biology, and microbial genomics.

Breakup by End-User:

Research Centers

Hospitals and Clinics

Pharmaceutical and Biotechnology Companies

Others

Pharmaceutical and biotechnology companies exhibit a clear dominance in the market

A detailed breakup and analysis of the market based on the end-user have also been provided in the report. This includes research centers, hospitals and clinics, pharmaceutical and, biotechnology companies, and others. According to the report, pharmaceutical and, biotechnology companies accounted for the largest market share.

Pharmaceutical and biotechnology companies are playing a major role in the market, emphasizing their significance in driving drug development and personalized medicine forward. These areas apply genomic data to identify novel targets for drugs, understand the genetic origins of diseases, and develop tailored treatments using individuals' genetic data. For instance, Illumina Inc., a top company in DNA sequencing and array-based technologies worldwide, partnered with Nashville Biosciences, LLC, a prominent clinical and genomic data company that is a subsidiary of Vanderbilt University Medical Center (VUMC), to reveal the five original members of the Alliance for Genomic Discovery (AGD). The extended agreement aims to quicken the treatment development process by conducting thorough genomics research and establishing a high-quality clinical genomics database. AbbVie, Amgen, AstraZeneca, Bayer, and Merck will pool their resources to fund the sequencing of 250,000 samples and can use the data for developing drugs and improving therapies.

Breakup by Region:

North America

United States

Canada

Asia Pacific

China

Japan

India

South Korea

Australia

Indonesia

Others

Europe

Germany

France

United Kingdom

Italy

Spain

Russia

Others

Latin America

Brazil

Mexico

Others

Middle East and Africa

North America leads the market, accounting for the largest genomics market share

The report has also provided a comprehensive analysis of all the major regional markets, which include North America (the United States and Canada); Europe (Germany, France, the United Kingdom, Italy, Spain, Russia, and others); Asia Pacific (China, Japan, India, South Korea, Australia, Indonesia, and others); Latin America (Brazil, Mexico, and others); and the Middle East and Africa. According to the report, North America represents the largest regional market for genomics.

North America holds the largest market share due to its advanced healthcare system, significant investment in research and development, and the presence of top pharmaceutical and biotechnology companies. Additionally, the region's advanced technology in genomics and bioinformatics, along with these factors, is fostering a favorable environment for the development and advancement of the genomics field. North America's strong position in the global market is supported by the close collaboration between academic and research institutions with the industry, leading to innovation and setting trends that impact global genomics practices and policies.

Competitive Landscape:

The market research report has also provided a comprehensive analysis of the competitive landscape in the market. Detailed profiles of all major companies have also been provided. Some of the major market players in the genomics industry include

23andMe, Inc

Agilent Technologies, Inc.

Bayer AG

BGI Group

Bio-Rad Laboratories, Inc.

Danaher Corporation

Illumina, Inc.

Oxford Nanopore Technologies

PerkinElmer, Inc.

Myriad Genetics, Inc.

F. Hoffmann-La Roche Ltd

Thermo Fisher Scientific Inc.

(Please note that this is only a partial list of the key players, and the complete list is provided in the report.)

Major players in the industry are involved in various strategic activities to uphold and strengthen their market presence. These businesses are making significant investments in research and development to launch new genomic technologies, services, and solutions that cater to their customers' changing needs. Working together, forming partnerships, and making acquisitions are important strategies that enable them to enhance their technological capabilities, enter new markets, and gain new genomic applications and intellectual property. Additionally, these top companies are focusing on improving their bioinformatics systems to manage and analyze the large amounts of data generated from genomic sequencing. This enables full solutions that help translate genomic findings into progress in clinical and agricultural sectors.

Genomics Market News:

October 30, 2023: 23andMe, Inc announced a fresh, non-exclusive data agreement with GSK plc that expands their partnership and grants GSK the ability to perform drug target discovery and other studies using the 23andMe database, the largest collection of genetic and phenotypic information from consenting participants that can be contacted again. According to a revision of their Collaboration Agreement, 23andMe is set to receive a $20 million initial payment for a one-year, non-exclusive data license.

March 14, 2023: Agilent Technologies, Inc. declared a collaboration with Agilent to provide a complete cancer analysis solution. The partnership will see the integration of the SOPHiA DDM Platform with Agilent's new Research Use Only SureSelect Cancer Comprehensive Genomic Profiling (CGP) Assay Kit. This will allow clinical researchers to precisely detect several biomarkers, reducing the chance of overlooking crucial information in cancer samples.

Key Questions Answered in This Report

  • 1. What was the size of the global genomics market in 2023?
  • 2. What is the expected growth rate of the global genomics market during 2024-2032?
  • 3. What are the key factors driving the global genomics market?
  • 4. What has been the impact of COVID-19 on the global genomics market?
  • 5. What is the breakup of the global genomics market based on the component?
  • 6. What is the breakup of the global genomics market based on the application?
  • 7. What is the breakup of the global genomics market based on the technology?
  • 8. What is the breakup of the global genomics market based on the end-user?
  • 9. What are the key regions in the global genomics market?
  • 10. Who are the key players/companies in the global genomics market?

Table of Contents

1 Preface

2 Scope and Methodology

  • 2.1 Objectives of the Study
  • 2.2 Stakeholders
  • 2.3 Data Sources
    • 2.3.1 Primary Sources
    • 2.3.2 Secondary Sources
  • 2.4 Market Estimation
    • 2.4.1 Bottom-Up Approach
    • 2.4.2 Top-Down Approach
  • 2.5 Forecasting Methodology

3 Executive Summary

4 Introduction

  • 4.1 Overview
  • 4.2 Key Industry Trends

5 Global Genomics Market

  • 5.1 Market Overview
  • 5.2 Market Performance
  • 5.3 Impact of COVID-19
  • 5.4 Market Forecast

6 Market Breakup by Component

  • 6.1 Products
    • 6.1.1 Market Trends
    • 6.1.2 Major Types
      • 6.1.2.1 Instruments and Software
      • 6.1.2.2 Consumables and Reagents
    • 6.1.3 Market Forecast
  • 6.2 Services
    • 6.2.1 Market Trends
    • 6.2.2 Major Types
      • 6.2.2.1 Core Genomics Services
      • 6.2.2.2 NGS-Based Services
      • 6.2.2.3 Biomarker Translation Services
      • 6.2.2.4 Computational Services
      • 6.2.2.5 Others
    • 6.2.3 Market Forecast

7 Market Breakup by Application

  • 7.1 Functional Genomics
    • 7.1.1 Market Trends
    • 7.1.2 Market Forecast
  • 7.2 Epigenomics
    • 7.2.1 Market Trends
    • 7.2.2 Market Forecast
  • 7.3 Biomarkers Discovery
    • 7.3.1 Market Trends
    • 7.3.2 Market Forecast
  • 7.4 Pathway Analysis
    • 7.4.1 Market Trends
    • 7.4.2 Market Forecast
  • 7.5 Others
    • 7.5.1 Market Trends
    • 7.5.2 Market Forecast

8 Market Breakup by Technology

  • 8.1 Sequencing
    • 8.1.1 Market Trends
    • 8.1.2 Market Forecast
  • 8.2 Microarray
    • 8.2.1 Market Trends
    • 8.2.2 Market Forecast
  • 8.3 Polymerase Chain Reaction
    • 8.3.1 Market Trends
    • 8.3.2 Market Forecast
  • 8.4 Nucleic Acid Extraction and Purification
    • 8.4.1 Market Trends
    • 8.4.2 Market Forecast
  • 8.5 Others
    • 8.5.1 Market Trends
    • 8.5.2 Market Forecast

9 Market Breakup by End-User

  • 9.1 Research Centers
    • 9.1.1 Market Trends
    • 9.1.2 Market Forecast
  • 9.2 Hospitals and Clinics
    • 9.2.1 Market Trends
    • 9.2.2 Market Forecast
  • 9.3 Pharmaceutical and Biotechnology Companies
    • 9.3.1 Market Trends
    • 9.3.2 Market Forecast
  • 9.4 Others
    • 9.4.1 Market Trends
    • 9.4.2 Market Forecast

10 Market Breakup by Region

  • 10.1 North America
    • 10.1.1 United States
      • 10.1.1.1 Market Trends
      • 10.1.1.2 Market Forecast
    • 10.1.2 Canada
      • 10.1.2.1 Market Trends
      • 10.1.2.2 Market Forecast
  • 10.2 Asia Pacific
    • 10.2.1 China
      • 10.2.1.1 Market Trends
      • 10.2.1.2 Market Forecast
    • 10.2.2 Japan
      • 10.2.2.1 Market Trends
      • 10.2.2.2 Market Forecast
    • 10.2.3 India
      • 10.2.3.1 Market Trends
      • 10.2.3.2 Market Forecast
    • 10.2.4 South Korea
      • 10.2.4.1 Market Trends
      • 10.2.4.2 Market Forecast
    • 10.2.5 Australia
      • 10.2.5.1 Market Trends
      • 10.2.5.2 Market Forecast
    • 10.2.6 Indonesia
      • 10.2.6.1 Market Trends
      • 10.2.6.2 Market Forecast
    • 10.2.7 Others
      • 10.2.7.1 Market Trends
      • 10.2.7.2 Market Forecast
  • 10.3 Europe
    • 10.3.1 Germany
      • 10.3.1.1 Market Trends
      • 10.3.1.2 Market Forecast
    • 10.3.2 France
      • 10.3.2.1 Market Trends
      • 10.3.2.2 Market Forecast
    • 10.3.3 United Kingdom
      • 10.3.3.1 Market Trends
      • 10.3.3.2 Market Forecast
    • 10.3.4 Italy
      • 10.3.4.1 Market Trends
      • 10.3.4.2 Market Forecast
    • 10.3.5 Spain
      • 10.3.5.1 Market Trends
      • 10.3.5.2 Market Forecast
    • 10.3.6 Russia
      • 10.3.6.1 Market Trends
      • 10.3.6.2 Market Forecast
    • 10.3.7 Others
      • 10.3.7.1 Market Trends
      • 10.3.7.2 Market Forecast
  • 10.4 Latin America
    • 10.4.1 Brazil
      • 10.4.1.1 Market Trends
      • 10.4.1.2 Market Forecast
    • 10.4.2 Mexico
      • 10.4.2.1 Market Trends
      • 10.4.2.2 Market Forecast
    • 10.4.3 Others
      • 10.4.3.1 Market Trends
      • 10.4.3.2 Market Forecast
  • 10.5 Middle East and Africa
    • 10.5.1 Market Trends
    • 10.5.2 Market Breakup by Country
    • 10.5.3 Market Forecast

11 SWOT Analysis

  • 11.1 Overview
  • 11.2 Strengths
  • 11.3 Weaknesses
  • 11.4 Opportunities
  • 11.5 Threats

12 Value Chain Analysis

13 Porters Five Forces Analysis

  • 13.1 Overview
  • 13.2 Bargaining Power of Buyers
  • 13.3 Bargaining Power of Suppliers
  • 13.4 Degree of Competition
  • 13.5 Threat of New Entrants
  • 13.6 Threat of Substitutes

14 Price Indicators

15 Competitive Landscape

  • 15.1 Market Structure
  • 15.2 Key Players
  • 15.3 Profiles of Key Players
    • 15.3.1 23andMe, Inc.
      • 15.3.1.1 Company Overview
      • 15.3.1.2 Product Portfolio
    • 15.3.2 Agilent Technologies, Inc.
      • 15.3.2.1 Company Overview
      • 15.3.2.2 Product Portfolio
      • 15.3.2.3 Financials
      • 15.3.2.4 SWOT Analysis
    • 15.3.3 Bayer Aktiengesellschaft
      • 15.3.3.1 Company Overview
      • 15.3.3.2 Product Portfolio
      • 15.3.3.3 Financials
      • 15.3.3.4 SWOT Analysis
    • 15.3.4 BGI Genomics Co. Ltd.
      • 15.3.4.1 Company Overview
      • 15.3.4.2 Product Portfolio
      • 15.3.4.3 Financials
    • 15.3.5 Bio-RAD Laboratories Inc.
      • 15.3.5.1 Company Overview
      • 15.3.5.2 Product Portfolio
      • 15.3.5.3 Financials
      • 15.3.5.4 SWOT Analysis
    • 15.3.6 Danaher Corporation
      • 15.3.6.1 Company Overview
      • 15.3.6.2 Product Portfolio
      • 15.3.6.3 Financials
      • 15.3.6.4 SWOT Analysis
    • 15.3.7 Illumina Inc.
      • 15.3.7.1 Company Overview
      • 15.3.7.2 Product Portfolio
      • 15.3.7.3 Financials
      • 15.3.7.4 SWOT Analysis
    • 15.3.8 Oxford Nanopore Technologies
      • 15.3.8.1 Company Overview
      • 15.3.8.2 Product Portfolio
      • 15.3.8.3 Financials
      • 15.3.8.4 SWOT Analysis
    • 15.3.9 PerkinElmer Inc.
      • 15.3.9.1 Company Overview
      • 15.3.9.2 Product Portfolio
    • 15.3.10 Myriad Genetics Inc.
      • 15.3.10.1 Company Overview
      • 15.3.10.2 Product Portfolio
    • 15.3.11 Roche Holding AG
      • 15.3.11.1 Company Overview
      • 15.3.11.2 Product Portfolio
      • 15.3.11.3 Financials
    • 15.3.12 Thermo Fisher Scientific Inc.
      • 15.3.12.1 Company Overview
      • 15.3.12.2 Product Portfolio
      • 15.3.12.3 Financials
      • 15.3.12.4 SWOT Analysis

List of Figures

  • Figure 1: Global: Genomics Market: Major Drivers and Challenges
  • Figure 2: Global: Genomics Market: Sales Value (in Billion US$), 2018-2023
  • Figure 3: Global: Genomics Market: Breakup by Component (in %), 2023
  • Figure 4: Global: Genomics Market: Breakup by Application (in %), 2023
  • Figure 5: Global: Genomics Market: Breakup by Technology (in %), 2023
  • Figure 6: Global: Genomics Market: Breakup by End-User (in %), 2023
  • Figure 7: Global: Genomics Market: Breakup by Region (in %), 2023
  • Figure 8: Global: Genomics Market Forecast: Sales Value (in Billion US$), 2024-2032
  • Figure 9: Global: Genomics (Products) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 10: Global: Genomics (Products) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 11: Global: Genomics (Services) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 12: Global: Genomics (Services) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 13: Global: Genomics (Functional Genomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 14: Global: Genomics (Functional Genomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 15: Global: Genomics (Epigenomics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 16: Global: Genomics (Epigenomics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 17: Global: Genomics (Biomarkers Discovery) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 18: Global: Genomics (Biomarkers Discovery) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 19: Global: Genomics (Pathway Analysis) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 20: Global: Genomics (Pathway Analysis) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 21: Global: Genomics (Other Applications) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 22: Global: Genomics (Other Applications) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 23: Global: Genomics (Sequencing) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 24: Global: Genomics (Sequencing) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 25: Global: Genomics (Microarray) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 26: Global: Genomics (Microarray) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 27: Global: Genomics (Polymerase Chain Reaction) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 28: Global: Genomics (Polymerase Chain Reaction) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 29: Global: Genomics (Nucleic Acid Extraction and Purification) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 30: Global: Genomics (Nucleic Acid Extraction and Purification) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 31: Global: Genomics (Other Technologies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 32: Global: Genomics (Other Technologies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 33: Global: Genomics (Research Centers) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 34: Global: Genomics (Research Centers) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 35: Global: Genomics (Hospitals and Clinics) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 36: Global: Genomics (Hospitals and Clinics) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 37: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 38: Global: Genomics (Pharmaceutical and Biotechnology Companies) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 39: Global: Genomics (Other End-Users) Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 40: Global: Genomics (Other End-Users) Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 41: North America: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 42: North America: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 43: United States: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 44: United States: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 45: Canada: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 46: Canada: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 47: Asia Pacific: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 48: Asia Pacific: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 49: China: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 50: China: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 51: Japan: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 52: Japan: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 53: India: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 54: India: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 55: South Korea: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 56: South Korea: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 57: Australia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 58: Australia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 59: Indonesia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 60: Indonesia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 61: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 62: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 63: Europe: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 64: Europe: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 65: Germany: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 66: Germany: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 67: France: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 68: France: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 69: United Kingdom: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 70: United Kingdom: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 71: Italy: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 72: Italy: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 73: Spain: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 74: Spain: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 75: Russia: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 76: Russia: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 77: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 78: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 79: Latin America: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 80: Latin America: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 81: Brazil: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 82: Brazil: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 83: Mexico: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 84: Mexico: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 85: Others: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 86: Others: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 87: Middle East and Africa: Genomics Market: Sales Value (in Million US$), 2018 & 2023
  • Figure 88: Middle East and Africa: Genomics Market Forecast: Sales Value (in Million US$), 2024-2032
  • Figure 89: Global: Genomics Industry: SWOT Analysis
  • Figure 90: Global: Genomics Industry: Value Chain Analysis
  • Figure 91: Global: Genomics Industry: Porter's Five Forces Analysis

List of Tables

  • Table 1: Global: Genomics Market: Key Industry Highlights, 2023 and 2032
  • Table 2: Global: Genomics Market Forecast: Breakup by Component (in Million US$), 2024-2032
  • Table 3: Global: Genomics Market Forecast: Breakup by Application (in Million US$), 2024-2032
  • Table 4: Global: Genomics Market Forecast: Breakup by Technology (in Million US$), 2024-2032
  • Table 5: Global: Genomics Market Forecast: Breakup by End-User (in Million US$), 2024-2032
  • Table 6: Global: Genomics Market Forecast: Breakup by Region (in Million US$), 2024-2032
  • Table 7: Global: Genomics Market: Competitive Structure
  • Table 8: Global: Genomics Market: Key Players